Additionally, GRK2 expression is decreased by ~50% in lymphocytes of RA patients, resulting in diminished GRK2-mediated chemokine receptor desensitization and enhanced T-cell chemotaxis to CCl4 [12]. The gene discussed is GRK2; the disease is rheumatoid arthritis.